PARP1 and asthma: We believe that the results of our study not only provide a stronger support for the role of PARP-1 in asthma, but they also introduce synthetic STAT6 degradation as a novel concept in the field of asthma to block lung inflammation and remodeling, as well as provide novel insights into the regulation of activated STAT6.